Acutus Medical Buy Hold or Sell Recommendation

AFIBDelisted Stock  USD 0.73  0.03  3.95%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Acutus Medical is 'Not Rated'. Macroaxis provides Acutus Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AFIB positions.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
In addition, we conduct extensive research on individual companies such as Acutus and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Acutus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Execute Acutus Medical Buy or Sell Advice

The Acutus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acutus Medical. Macroaxis does not own or have any residual interests in Acutus Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acutus Medical's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Acutus MedicalBuy Acutus Medical
Not Rated
For the selected time horizon Acutus Medical has a Risk Adjusted Performance of 0.036, Jensen Alpha of 0.2182, Total Risk Alpha of 0.0254, Sortino Ratio of 0.0236 and Treynor Ratio of (0.09)
We provide trade advice to complement the prevailing expert consensus on Acutus Medical. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Acutus Medical is not overpriced, please confirm all Acutus Medical fundamentals, including its price to sales, net income, debt to equity, as well as the relationship between the gross profit and cash per share . As Acutus Medical appears to be a penny stock we also recommend to validate its number of shares shorted numbers.

Acutus Medical Trading Alerts and Improvement Suggestions

Acutus Medical is not yet fully synchronised with the market data
Acutus Medical has some characteristics of a very speculative penny stock
Acutus Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (11.92 M) with loss before overhead, payroll, taxes, and interest of (15.55 M).
Acutus Medical currently holds about 88.97 M in cash with (63.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Acutus Medical Returns Distribution Density

The distribution of Acutus Medical's historical returns is an attempt to chart the uncertainty of Acutus Medical's future price movements. The chart of the probability distribution of Acutus Medical daily returns describes the distribution of returns around its average expected value. We use Acutus Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acutus Medical returns is essential to provide solid investment advice for Acutus Medical.
Mean Return
0.18
Value At Risk
-8.42
Potential Upside
7.78
Standard Deviation
5.32
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acutus Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 8475 shares by Takeo Mukai of Acutus MedicalInc at 0.21 subject to Rule 16b-3 [view details]

Acutus Medical Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acutus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Acutus Medical Buy or Sell Advice

When is the right time to buy or sell Acutus Medical? Buying financial instruments such as Acutus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Acutus Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run SRI Sustainable Growth Thematic Idea Now

SRI Sustainable Growth
SRI Sustainable Growth Theme
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in Acutus Stock

If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.